Navigation Links
Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea
Date:8/2/2011

Apnex Medical, Inc. and HGNS System

Apnex Medical was founded in 2006 with a mission to pioneer medical innovations to improve the health of people with sleep disordered breathing. The company has developed a proprietary medical device for the treatment of OSA.

The Apnex HGNS System is an implantable therapy that is intended to work by activating the muscles in the upper airway to ensure that the airway remains open during sleep. The system detects the patient's breathing and delivers mild stimulation to the hypoglossal nerve, the nerve that controls the muscles of the tongue, to keep the airway open. The stimulation is timed to a patient's own breathing pattern. The HGNS System is designed to work only when the patient is asleep through a handheld controller.

About OSA

According to the World Health Organization approximately 100 million people worldwide have OSA. It occurs because of blockage of breathing during sleep. This can deprive OSA sufferers of deep restful sleep and lead to sleepiness and fatigue. OSA sufferers are also at an increased risk for a variety of health conditions, including high blood pressure, coronary artery disease, diabetes and stroke. Untreated OSA is also associated with an increased risk of death. Current OSA treatments are not always successful or well tolerated. The Apnex device is designed to provide an alternative treatment for OSA that addresses these problems.

More information on the Apnex Clinical Study can be found at www.SleepApneaTrial.com. To learn if you might qualify for the study go to this website or call 1-888-975-3370.

To request additional information, please contact:

Apnex Medical, Inc.
2890 Centre Pointe Drive
St. Paul, MN 55113 USA
+1.651.757.4300
www.apnexmedical.com

CAUTION: The Apnex HGNS System is an inve
'/>"/>

SOURCE Apnex Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Apnex Medical, Inc. Raises Additional $14 Million
2. Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
3. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
4. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
7. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
8. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
9. Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
10. Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study
11. China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... WESTMINSTER, Colo. , June 20, 2013 ... Surefire Medical today announced a sales and marketing partnership ... catheters for the interventional radiology and oncology markets. ... range of products in the company,s rapidly growing ... . Sirtex reported a 30 per cent growth ...
(Date:6/20/2013)... , June 20, 2013 Today ... mark the launch of a new programme to control the ... Jacobina in the State of Bahia. In previous ... is possible to rapidly reduce the number of dengue mosquitoes ... the level of these mosquitoes were reduced by 96% within ...
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients ... suggested ibrutinib may be effective and generally well-tolerated in ... a separate study examining the safety and efficacy of ...
Breaking Medicine Technology:Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6
... Emdeon Inc. (NYSE: EM ), a leading provider ... acquisition of Chapin Revenue Cycle Management, LLC ("Chapin"). Based in ... revenue cycle services including accounts receivable management, medical denials, appeals and ... , ...
... June 21 TMS Health, a leading Healthcare Communications Company ... PA. , , ... TMS Health has enjoyed strong growth as a specialized healthcare ... and marketing reach of its clients. The company provides solutions for ...
Cached Medicine Technology:Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 2Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 3Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 4TMS Health Announces New State-of-the Art Facility in Moosic, PA 2
(Date:6/20/2013)... The ISA (International Seabuckthorn Association) founded ... announced their 6th annual international conference to take place ... , Bruce McMullin , Founder and CEO of ... for introducing the benefits of sea buckthorn to the ... Sibu grows and harvests sea buckthorn berries in the ...
(Date:6/20/2013)... Indianapolis, IN (PRWEB) June 20, 2013 ... Many employers are concerned that this cost percentage will ... burden of caring for both aging parents and adult ... claims management can either provide workers a road block, ... , United Benefit Advisors (UBA), in ...
(Date:6/20/2013)... York, New York (PRWEB) June 20, 2013 ... protein folding and misfolding, Navneet Tyagi has ... Alzheimer’s disease. Throughout the myriad of scientific research that ... his commitment of identifying early onset of these severe ... through early diagnosis, more medical researchers will be able ...
(Date:6/20/2013)... Denton, TX (PRWEB) June 20, 2013 ... has maintained a wide range of outpatient and inpatient ... psychiatric issues, including those who are children. As a ... UBH explains that it is critical to diagnose mental ... action. However, according to a recent article ...
(Date:6/20/2013)... June 20, 2013 Rampant staph infections ... to fight this scourge is being successfully deployed by ... direct contact and by touching items that are contaminated ... As noted by the San Francisco Chronicle , ... become infected during hospital stays, and at least 90,000 ...
Breaking Medicine News(10 mins):Health News:Sibu, LLC CEO, Bruce McMullin to be Amongst Distinguished Attendees at ISA Conference 2Health News:United Benefit Advisors and Symetra Host Absence Management Webinar 2Health News:United Benefit Advisors and Symetra Host Absence Management Webinar 3Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 2Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 3Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 2Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 3Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 2Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 3
... gene respond well to targeted therapy , , SUNDAY, June ... the normal version of a particular gene are more ... adding the targeted therapy Erbitux to chemotherapy. , Some ... "wild-type" form of the gene, according to the new ...
... cells, hasten death, study says , , SUNDAY, June 1 ... in cancer patients may actually speed progression of the ... found a way to determine who those individuals are. ... whether a patient is susceptible to having their tumor ...
... study suggests , , SUNDAY, June 1 (HealthDay News) -- ... value in helping to prevent lung cancer. , Researchers ... on the U.S. market, may reduce levels of a ... presented its findings Sunday at the American Society of ...
... combination of two different biotherapies may be beneficial for ... Pittsburgh Cancer Institute (UPCI) study presented at the 44th ... (ASCO) in Chicago. , Researchers in the melanoma and ... treatments that stimulate the immune system to fight cancer ...
... common types, study says , , SUNDAY, June 1 (HealthDay News) ... or adolescents are much more likely than other people to ... disease (HD), a cancer of the lymph nodes, has a ... be at future risk of developing second cancers other than ...
... in determining how much fathers get involved in taking care ... of 97 couples found that fathers were more involved in ... encouragement from their wife or partner. , In fact, this ... mothers views about how involved dads should be, the overall ...
Cached Medicine News:Health News:Erbitux Works Well for Two-Thirds of Colon Cancer Patients 2Health News:Erbitux Works Well for Two-Thirds of Colon Cancer Patients 3Health News:Anemia Drugs May Speed Tumor Growth in Some Cancer Patients 2Health News:Anemia Drugs May Speed Tumor Growth in Some Cancer Patients 3Health News:Celebrex May Reduce Levels of Lung Cancer Biomarker 2Health News:Celebrex May Reduce Levels of Lung Cancer Biomarker 3Health News:Young Hodgkin Survivors Face Later Risk of Second Cancers 2Health News:Mom's behavior key to dad's involvement in child care 2Health News:Mom's behavior key to dad's involvement in child care 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: